Celgene Corp. /de/, 10% Owner at CRISPR Therapeutics AG (CRSP), sold 1,112,446 shares at $19.10 ($21.1M) on 2017-11-03, disclosed to the SEC on 2017-12-07.
Open-market sale of $21.1M CRSP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.10 | 22,759 | $435K | 2.1% |
| 2 | $18.89 | 79,327 | $1.5M | 7.1% |
| 3 | $18.54 | 23,000 | $426K | 2.0% |
| 4 | $18.06 | 16,875 | $305K | 1.4% |
| 5 | $17.08 | 20,000 | $342K | 1.6% |
| 6 | $17.28 | 10,000 |
| $173K |
| 0.8% |
| 7 | $17.76 | 65,093 | $1.2M | 5.5% |
| 8 | $17.19 | 14,907 | $256K | 1.2% |
| 9 | $17.67 | 15,000 | $265K | 1.3% |
| 10 | $18.39 | 105,000 | $1.9M | 9.1% |
| 11 | $18.44 | 51,282 | $946K | 4.5% |
| 12 | $19.02 | 158,718 | $3.0M | 14.3% |
| 13 | $19.76 | 256,000 | $5.1M | 24.0% |
| 14 | $20.00 | 26,010 | $520K | 2.5% |
| 15 | $19.75 | 27,990 | $553K | 2.6% |
| 16 | $19.22 | 5,080 | $98K | 0.5% |
| 17 | $19.25 | 4,263 | $82K | 0.4% |
| 18 | $19.04 | 12,666 | $241K | 1.1% |
| 19 | $19.10 | 87,991 | $1.7M | 8.0% |
| 20 | $19.47 | 30,485 | $594K | 2.8% |
| 21 | $19.25 | 80,000 | $1.5M | 7.3% |
| Total | $18.98 avg | 1,112,446 | $21.1M | 100% |
| Filing → |
| XLRN | BUY | 2019-01-22 | $30.4M | — | Filing → |
| AGIO | BUY | 2018-01-23 | $57.0M | — | Filing → |
| XLRN | BUY | 2017-09-25 | $27.6M | — | Filing → |